These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11499308)

  • 1. Nitric oxide and control of pulmonary vascular resistance.
    Cremona G
    Monaldi Arch Chest Dis; 2001 Apr; 56(2):158-64. PubMed ID: 11499308
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitric oxide and hypoxic pulmonary hypertension.
    Leeman M; Naeije R
    Eur Respir J; 1995 Apr; 8(4):513-4. PubMed ID: 7545132
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitric-oxide-mediated zinc release: a new (modulatory) pathway in hypoxic pulmonary vasoconstriction.
    Weissmann N
    Circ Res; 2008 Jun; 102(12):1451-4. PubMed ID: 18566310
    [No Abstract]   [Full Text] [Related]  

  • 4. [Regulation of pulmonary circulation by the vascular endothelium].
    Leeman M
    Bull Mem Acad R Med Belg; 1999; 154(5-6):245-51; discussion 251-2. PubMed ID: 10687243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of pulmonary vascular tone in the perinatal period.
    Fineman JR; Soifer SJ; Heymann MA
    Annu Rev Physiol; 1995; 57():115-34. PubMed ID: 7778860
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of pulmonary vascular control in normal and injured lungs.
    McIntyre RC; Harken AH; Fullerton DA
    Surgery; 1994 Mar; 115(3):273-5. PubMed ID: 8128350
    [No Abstract]   [Full Text] [Related]  

  • 7. Nitric oxide reverses acute hypoxic pulmonary hypertension in the newborn piglet.
    Etches PC; Finer NN; Barrington KJ; Graham AJ; Chan WK
    Pediatr Res; 1994 Jan; 35(1):15-9. PubMed ID: 8134192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current insights on the pathogenesis of pulmonary arterial hypertension.
    Perros F; Dorfmüller P; Humbert M
    Semin Respir Crit Care Med; 2005 Aug; 26(4):355-64. PubMed ID: 16121311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature.
    Berg JT
    J Appl Physiol (1985); 2007 Oct; 103(4):1455. PubMed ID: 17916681
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of applied tension and nitric oxide on responses to endothelins in rat pulmonary resistance arteries: effect of chronic hypoxia.
    MacLean MR; McCulloch KM
    Br J Pharmacol; 1998 Mar; 123(5):991-9. PubMed ID: 9535030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled nitric oxide, right ventricular efficiency, and pulmonary vascular mechanics: selective vasodilation of small pulmonary vessels during hypoxic pulmonary vasoconstriction.
    Hillman ND; Cheifetz IM; Craig DM; Smith PK; Ungerleider RM; Meliones JN
    J Thorac Cardiovasc Surg; 1997 Jun; 113(6):1006-13. PubMed ID: 9202680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide in the regulation of vascular systemic resistance.
    Rizzoni D; Porteri E; Agabiti-Rosei E
    Monaldi Arch Chest Dis; 2001 Apr; 56(2):153-4. PubMed ID: 11499306
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypoxic pulmonary vasoconstriction in cardiothoracic surgery: basic mechanisms to potential therapies.
    Tsai BM; Wang M; Turrentine MW; Mahomed Y; Brown JW; Meldrum DR
    Ann Thorac Surg; 2004 Jul; 78(1):360-8. PubMed ID: 15223473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of endogenous nitric oxide synthesis enhances acute hypoxic pulmonary vasoconstriction].
    Cao WB; Zhu YJ; Luo WC
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Jun; 17(3):148-51, 189. PubMed ID: 7834769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension.
    Voelkel NF; Tuder RM
    Pulm Pharmacol Ther; 1997; 10(5-6):231-41. PubMed ID: 9778486
    [No Abstract]   [Full Text] [Related]  

  • 16. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia.
    Weissmann N; Manz D; Buchspies D; Keller S; Mehling T; Voswinckel R; Quanz K; Ghofrani HA; Schermuly RT; Fink L; Seeger W; Gassmann M; Grimminger F
    Thromb Haemost; 2005 Sep; 94(3):630-8. PubMed ID: 16268482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs.
    Hubloue I; Rondelet B; Kerbaul F; Biarent D; Milani GM; Staroukine M; Bergmann P; Naeije R; Leeman M
    Crit Care; 2004 Aug; 8(4):R163-71. PubMed ID: 15312214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of NO and prostaglandins in acute hypoxic vasoconstriction in sheep pulmonary veins.
    Uzun O; Demiryurek AT
    Pharmacology; 2006; 77(3):122-9. PubMed ID: 16717478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo.
    Persson MG; Gustafsson LE; Wiklund NP; Moncada S; Hedqvist P
    Acta Physiol Scand; 1990 Dec; 140(4):449-57. PubMed ID: 1707210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice.
    Liu R; Evgenov OV; Ichinose F
    J Appl Physiol (1985); 2005 Feb; 98(2):748-52. PubMed ID: 15465885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.